CDPQ Venture Capital
No summary available yet.
CDPQ brings serious capital and patient money, but you're dealing with a pension fund, not a traditional VC shop. The upside: they write big checks, don't need quick exits, and have deep pockets for follow-ons. The reality check: decision-making can be glacial, they're risk-averse by nature, and you'll navigate more bureaucracy than a typical fund. They're excellent for growth-stage companies that want stability over speed, but if you need fast decisions or aggressive growth strategies, look elsewhere. Their Quebec focus means they really understand the Canadian market, which is gold if that's your target.
- —Best for: Growth-stage companies needing patient capital and operational stability
- —Watch out for: Slow decision-making and pension fund bureaucracy
- —Known for: Large checks, ESG focus, and long-term partnership approach
CDPQ invests pension fund capital across growth and late-stage companies with a focus on sustainable returns and ESG considerations. They target established companies with strong fundamentals rather than early-stage moonshots, emphasizing diversification across sectors and geographies.
Series B+ growth equity with $50M+ checks, focusing on technology, healthcare, infrastructure, and sustainable industries. Heavy concentration in North American companies with proven revenue and clear paths to profitability.
Former McKinsey partner with deep experience in growth equity and operational scaling. Known for methodical due diligence and hands-on portfolio support, though some founders find the pension fund bureaucracy slower than traditional VC shops.
Previously at Real Ventures and Google Ventures, brings Silicon Valley perspective to CDPQ's tech investments. Respected for technical due diligence but operates within CDPQ's more conservative risk framework than typical VCs.
Have a specific question about CDPQ Venture Capital?
Ask Bernie →